Clinical trial

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

NCT00420355

Study summary

ClinicalTrials.gov

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record atazanavir Normalized identity: atazanavir View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention lopinavir/ritonavir Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2007-04-01

PhasePHASE4

Conditions

HIV Infectionverified · MONDO: HIV infectious disease

Interventions

atazanavirDRUG · verified · RxNorm: atazanavir

lopinavir/ritonavirDRUG

Sponsors & collaborators

University of Oklahomalead sponsor

Abbottcollaborator

Mapped research locations

Oklahoma CityOklahoma, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00420355 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.